Editorial: Drugging p53 for non-cancer diseases.

Saved in:

Bibliographic Details
Title:	Editorial: Drugging p53 for non-cancer diseases.
Authors:	Jiang F; Shandong Key Laboratory of Cardiovascular Proteomics and Department of Geriatric Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China., Li CG; NICM Health Research Institute, Western Sydney University, Westmead, NSW, Australia., Seto SW; NICM Health Research Institute, Western Sydney University, Westmead, NSW, Australia.; Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong SAR, China.; Research Centre for Chinese Medicine Innovation, The Hong Kong Polytechnic University, Hong Kong SAR, China.
Source:	Frontiers in pharmacology [Front Pharmacol] 2022 Nov 30; Vol. 13, pp. 1101742. Date of Electronic Publication: 2022 Nov 30 (Print Publication: 2022).
Publication Type:	Editorial
Journal Info:	Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1663-9812
DOI:	10.3389/fphar.2022.1101742